Search

You searched for "drops"

1632 results found

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 1)

3 February 2023 | | EYE - General
Part 1: Epidemiology, classification, radiology, histopathology and associations (see Part 2 here) In this two-part series, Li Yen Goh reviews IgG4 disease and reminds us of diagnostic challenges faced. Introduction Immunoglobulin G4 (IgG4) disease is a recently recognised idiopathic systemic...

What's trending Oct/Nov 2021

1 October 2021 | | EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #cataracts #holography #simulation Cataracts are the major cause of blindness globally and innovating novel management strategies remains as important as ever...

Broadening horizons in ophthalmology: crafting a varied elective experience

24 January 2024 | | EYE - General
The elective period for medical students is a unique opportunity to immerse oneself in a field of interest. For students interested in ophthalmology, this can offer a dedicated experience for what can otherwise be quite limited through undergraduate rotations. Alongside...

Pituitary tumours: why are they so often missed?

1 October 2017 | | EYE - Neuro-ophthalmology
Part 3: Clinical features, assessment and management (see also Part 2, and Part 1) As previously mentioned in this treatise [1] pituitary tumours are common, occur in all age groups and can present with anything from minimal visual symptoms to...

Principles of management

1 August 2016 | | EYE - Cataract, EYE - Cornea, EYE - Pathology
Whatever section of pathology is to blame and wherever it strikes, the aim of treatment is always the same. Find the cause if you can. Establish the effects of the cause. Halt the pathological process if you can. Reverse its...

Brexit, for richer, for poorer: prospects for post-withdrawal Britain

1 July 2017 | | EYE - General
The people of the United Kingdom voted by 52% to 48% to leave the European Union (EU) in June 2016, a referendum decision intended by a slim majority to restore national self-determination and achieve what many believed to be a...

Glaucoma Awareness Week: Glaucoma UK to focus on hereditary nature of disease

7 June 2021
With so many people looking forward to reuniting with family and friends, Glaucoma Awareness Week will focus on the fact that glaucoma can be hereditary and the importance of loved ones in the lives of patients with the disease.

RNIB and Abertay University hold event to reboot gaming to make it more accessible for those with sight loss

3 October 2022
Sight loss charity Royal National Institute of Blind People (RNIB) and Abertay University in Dundee will host a pioneering Accessible Gaming Symposium this week.

AI breakthrough in detecting leading cause of childhood blindness

3 May 2023 | AI, blindness, Children
An artificial intelligence (AI) tool could be an effective way of identifying retinopathy of prematurity (ROP), the leading cause of childhood blindness in middle-income countries, finds a new study led by UCL and Moorfields Eye Hospital researchers.

New SEE Summit speaker announced

28 June 2023 | 2023, ANDREW CLARK, SEE, SUMMIT, PLASTIC
ABDO has announced that Andrew Clark, BSc (Hons), MSc, AIEMA, will be speaking at the SEE Summit 2023.

Scotland’s young blind voices boosted by new funding

1 May 2025 | charity, news, UK, funding, Haggeye, RNIB
A youth-led forum for blind and partially sighted young people has secured vital funding, enabling a new period of opportunity for young blind and partially sighted people across Scotland. Haggeye, operated by national sight loss charity, RNIB Scotland, will expand...

First medical AI model with globally representative data

22 September 2025 | NHS, Medical AI, Eye Images, Retina, UCL, ophthalmology
Quest to build the first medical AI foundation model with globally representative data. A research consortium of over 100 study groups in more than 65 countries has launched the Global RETFound initiative, a collaborative effort to develop the first globally...